A recent study suggests that CBD holds potential in preventing and alleviating Alzheimer’s disease (AD), a neurodegenerative disorder affecting over 6 million individuals in the United States without a current cure.
Despite the legalization of medical cannabis in the United Kingdom (U.K.) in 2018, it has not yet been endorsed through clinical studies and remains scarcely available as a prescription option within the National Health Services (NHS).
The potential for utilizing cannabinoids from hemp as the foundation for natural pesticides has been highlighted in research conducted at Cornell University.
